Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry
Leonardo De Luca, Marcello Arca, Pier Luigi Temporelli, Jennifer Meessen, Carmine Riccio, Paolo Bonomo, Angela Rita Colavita, Domenico Gabrielli, Michele Massimo Gulizia, Furio Colivicchi
Topics & Concepts
MedicineEzetimibeStatinAtherosclerotic cardiovascular diseaseInternal medicineEvolocumabCohortProspective cohort studyDiseaseCardiologyCholesterolLipoproteinApolipoprotein A1Lipoproteins and Cardiovascular HealthHIV-related health complications and treatmentsAtherosclerosis and Cardiovascular Diseases